Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

INFLIXIMAB for Psoriatic arthropathy: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5,290 adverse event reports in the FDA FAERS database where INFLIXIMAB was used for Psoriatic arthropathy.

Most Reported Side Effects for INFLIXIMAB

Side Effect Reports % Deaths Hosp.
Off label use 34,801 24.8% 2,600 9,509
Drug ineffective 33,738 24.1% 1,689 7,293
Condition aggravated 16,616 11.9% 1,624 5,325
Rheumatoid arthritis 16,251 11.6% 1,877 4,035
Pain 15,061 10.7% 1,800 4,291
Fatigue 13,473 9.6% 1,897 3,946
Arthralgia 13,441 9.6% 1,616 4,319
Infusion related reaction 12,946 9.2% 1,934 4,087
Product use issue 12,752 9.1% 1,066 3,577
Drug intolerance 11,173 8.0% 1,526 3,180
Intentional product use issue 11,028 7.9% 1,280 3,261
Rash 10,768 7.7% 1,847 3,624
Alopecia 10,374 7.4% 1,581 2,633
Joint swelling 9,853 7.0% 1,981 3,360
Contraindicated product administered 9,618 6.9% 1,254 2,721

Other Indications for INFLIXIMAB

Crohn's disease (40,796) Rheumatoid arthritis (28,804) Product used for unknown indication (27,101) Colitis ulcerative (21,373) Ankylosing spondylitis (5,584) Inflammatory bowel disease (3,697) Psoriasis (3,143) Juvenile idiopathic arthritis (1,318) Colitis (1,248) Behcet's syndrome (789)

Other Drugs Used for Psoriatic arthropathy

ADALIMUMAB (47,183) ETANERCEPT (39,876) SECUKINUMAB (38,507) APREMILAST (33,990) CERTOLIZUMAB PEGOL (10,537) METHOTREXATE (6,997) RISANKIZUMAB-RZAA (6,970) TOFACITINIB (6,384) USTEKINUMAB (5,909) IXEKIZUMAB (5,798)

Related Pages

INFLIXIMAB Full Profile All Psoriatic arthropathy Drugs INFLIXIMAB Demographics INFLIXIMAB Timeline